Ibogaine Isn't Only in Iboga: The Other Plants That Contain It
Nearly every article about ibogaine's botanical origin stops at one sentence: it comes from the root bark of Tabernanthe iboga, a shrub native to Gabon and neighboring countries. That sentence is accurate but incomplete. Ibogaine, or alkaloids closely related to it, shows up across a surprisingly wide range of plants in the Apocynaceae family, scattered from Central Africa to French Guiana to Madagascar. Most of these species never entered any treatment protocol and barely get mentioned outside specialist botanical literature, but they matter for understanding how ibogaine supply, sustainability, and plant conservation actually work.
Tabernanthe elliptica: The Congo's Near-Twin of Iboga
A 1976 study published in Plantes Médicinales et Phytothérapie examined this plant under the name Daturicarpa elliptica, collected in the Republic of Congo. Botanists have since folded the genus Daturicarpa into Tabernanthe, so the currently accepted name is Tabernanthe elliptica (Stapf) Leeuwenberg, making it a direct taxonomic relative of iboga itself rather than merely a lookalike. Researchers at the time already noted it was difficult to distinguish from Tabernanthe iboga except through secondary botanical characteristics, which in hindsight makes sense given how closely related the two turned out to be. Its alkaloid content was substantial: the study reported 5.6 percent total alkaloids in the root bark, of which roughly 80 percent was ibogaine itself, alongside 2.4 percent total alkaloids in the stem bark at a similar 80 percent ibogaine proportion. Those figures put this species' root bark concentration in the same range as iboga itself, yet the plant has no established role in any treatment tradition or modern clinical sourcing chain.
Madagascar's Tabernaemontana Relatives, Formerly Classified as Pandaca
Two related species studied in Madagascar, originally described under the now-obsolete genus name Pandaca, also tested positive for ibogaine. Pandaca speciosa is today classified as Tabernaemontana humblotii (Baill.) Pichon, and Pandaca eusepala is now Tabernaemontana eusepala, following the taxonomic consolidation of Pandaca into the broader Tabernaemontana genus. Research on what is now called Tabernaemontana humblotii reported root bark yielding 3.1 percent total alkaloids, of which about 30 percent was ibogaine, with stem bark showing lower concentrations around 2.1 percent total alkaloids at 20 percent ibogaine. Tabernaemontana eusepala's root bark came in slightly lower, at 2.8 percent total alkaloids including roughly 15 percent ibogaine. Neither plant grows anywhere near Gabon, which underscores that ibogaine production in nature is not confined to a single geographic pocket of Central Africa.
Peschiera Echinata: A South American Entry in the Family
Not every ibogaine-containing plant is African. Peschiera echinata (now generally classified as Tabernaemontana echinata), studied growing in French Guiana, yielded numerous distinct alkaloids including ibogaine, according to phytochemical research into that species published in the 1970s. Reported alkaloid content varied sharply by plant part, from roughly 1.26 grams per kilogram in root bark to 20.4 grams per kilogram in leaves, though the specific proportion attributable to ibogaine itself was not isolated in that particular analysis. The existence of a South American relative in the same alkaloid family is a detail that rarely makes it into mainstream coverage of ibogaine's origins.
Tabernaemontana Species: Widespread but Dilute
The genus Tabernaemontana, which spans a huge range across tropical Africa and Asia, includes several species documented to contain ibogaine or close relatives, generally at much lower concentrations than Tabernanthe iboga. A phytochemical survey of Tabernaemontana crassa, a species occurring from Sierra Leone through Uganda and down to Angola and Tanzania, found that 800 grams of stem bark yielded only 12 milligrams of ibogaine, a concentration several orders of magnitude lower than what root bark from dedicated iboga sources provides. Tabernaemontana divaricata, sometimes called Tagar, was sold commercially as an extract in the late 1990s by small ethnobotanical suppliers, marketed as containing "ibogaine-like" alkaloids, though it does not contain meaningful ibogaine itself, only structurally related compounds with unclear and largely unstudied effects.
Not Always a Different Species: The Zaire "Tabernanthe pubescens" Case
One correction is worth making explicitly, because it illustrates how easily botanical nomenclature history gets tangled with chemistry. A sample from Zaire once described under the name Tabernanthe pubescens showed striking alkaloid concentration in its root bark, around 5.6 percent total alkaloids, essentially matching Tabernanthe iboga's own reported range, while its stem bark came in substantially lower at 2.1 percent. That name is no longer in use as a distinct species: current taxonomic treatments list Tabernanthe pubescens as a synonym of Tabernanthe iboga itself, meaning the Zaire sample represents a regional population or chemotype of iboga rather than a separate relative. The underlying data point still stands and is genuinely useful: it shows that even within a single species, alkaloid distribution between root bark and stem bark can vary by a factor of nearly three, which has direct implications for sustainable harvesting. A population or chemotype concentrating its alkaloids in stem bark rather than root bark can be harvested without killing the plant, the same sustainability argument that applies to Voacanga africana as a source for semisynthetic ibogaine.
Why This Matters Beyond Botanical Trivia
Three practical implications follow from this wider picture. First, the conservation pressure on Tabernanthe iboga, driven by rising global demand and the fact that root harvesting kills the plant, is not an unsolvable problem defined by a single endangered species. Alternative botanical sources exist, some already used in semisynthetic production, and documenting them more thoroughly could meaningfully reduce pressure on wild iboga populations that Gabon's Bwiti communities depend on for an unrelated, non-negotiable cultural purpose. Second, any product claiming to contain "ibogaine-like" compounds from an unspecified Tabernaemontana or Voacanga source should be read with real skepticism, since concentration varies by a factor of a thousand or more between species and even between plant parts of the same species, exactly the kind of ambiguity that produced the diluted commercial tincture scandal documented in ibogaine research circles in the late 1990s. Third, this botanical diversity has not been systematically re-examined with modern analytical chemistry. Most of the yield figures referenced here come from phytochemical surveys conducted decades ago, during the same era that produced the extraction and purification methods this site has covered elsewhere, and nobody appears to have revisited them using contemporary mass spectrometry and chromatography standards.
Practical Takeaway
If you encounter a supplement, extract, or "iboga alternative" product referencing any of these botanical names, treat the absence of a stated alkaloid concentration as a meaningful gap, not a minor omission. The difference between a plant containing 5.6 percent ibogaine in its root bark and one containing 12 milligrams per 800 grams of stem bark is not a rounding error. It is the difference between a product capable of producing a clinically relevant effect and one that functionally contains none.